# JAZZ — Jazz Pharmaceuticals · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** JAZZ  
**Sources:** 20  
**Published:** 2026-10-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-jazz-jazz-pharmaceuticals-catalysts-narrative-risks-5946

---

# Jazz Pharmaceuticals (NASDAQ: JAZZ) — Research Summary

*All figures are point-in-time as of 2026-11-09. The stock closed at $234.76 (+3.27%) on November 6, 2026, and traded at $237.00 after hours [[13]](https://finance.yahoo.com/quote/JAZZ/analysis/), [[17]](https://stockanalysis.com/stocks/jazz/forecast/).*

## Recent Catalysts (roughly August–November 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-jazz-jazz-pharmaceuticals-catalysts-narrative-risks-5946 (free to sign up)._
